SCDAA 46th Annual National Convention has ended

Create Your Own Event

SCDAA 46th Annual National Convention

Celebrating Diversity Within the Sickle Cell Community: Commitment, Innovation, Practice

←View All Dates

7:00am EDT

General Evaluation Form Nursing Evaluation Form Social Worker Evaluation Form

7:30am EDT

Breakfast/ Poster Viewing Harborview Super Power Hour Harborview

8:30am EDT

PLENARY SESSION III Real Life Experience with Transplantation: Patient and Family Perspective Constellation A Real Life Experiece wiith Transplantation: Patient and Family Perspective Constellation A

9:30am EDT

Charles F. Whitten, MD Memorial Lecture Constellation A

10:00am EDT

Diversity Panel LaTonya Kittles, Pfizer Constellation A

11:30am EDT

Self-Advocacy 101 for Individuals with SCD Baltimore/ Annapolis Community Health Worker Training President Healing the Healer Provider Session Constellation C Prolong Focus Group Pratt/Calvert Patient Family Session I Pratt/Calvert

12:00pm EDT

Finding your Voice between the Patient and Caregiver Baltimore/ Annapolis American Red Cross (Luncheon) Frederick/Columbia Prolong Focus Group Luncheon Camden/Lombard

12:15pm EDT

Lunch on Your Own IASCHAA Constellation D

1:30pm EDT

Lonzie Lee Jones Patient Advocacy Symposium Constellation A

3:00pm EDT

Break Constellation EF

3:15pm EDT

Effect Of Long Term Treatment With Sc411 On Sickle Cell Crisis Rate In Children With Sickle Cell Disease Constellation C Patient and Caregiver Perspectives on Areas of Burden In Sickle Cell Disease Management Baltimore/ Annapolis Discovering And Breaking Down Barriers: Improving Compliance with Appointments in the Pediatric Sickle Cell Clinic Constellation D Strategies And Next Steps For Improving Sickle Cell Disease Care: Highlights From The Sickle Cell Disease Treatment Demonstration Program (SCDTDP) Frederick/Columbia Striving in the Workforce with Sickle Cell Pratt/Calvert Simultaneous Session I Baltimore/ Annapolis

3:30pm EDT

Compassionate-Use Voxelotor (GBT440) For Up To 2 Years In Patients With Severe Sickle Cell Disease And Life-Threatening Comorbidities Constellation C Finding SCD Patients In Michigan - A Case Study Baltimore/ Annapolis The Opioid Epidemic And CDC Guidelines: A Case Of An Unfortunate Consequences Paved By Good Intentions Constellation D

3:45pm EDT

Crizanlizumab 5.0 Mg/Kg Increased the Time to First On-Treatment Sickel Cell Pain Crisis (SCPC) and the Likelihood of not Experiencing SCPC While on Treatment: Subgroup Analyses of the Phase 2 Sustain Study Constellation C The Communication, Awareness, Relationship and Empowerment (C.A.R.E.) Model: An Effective Tool for Engaging Urban Communities in Community-Based Participatory Research Baltimore/ Annapolis Availability of Information on Blood and Marrow Transplantation (BMT) Coverage Benefits for Patients with Sickle Cell Disease (SCD) Enrolled in Medicaid Constellation D

4:00pm EDT

Parent and Youth Barriers to Hydroxyurea Adherence in Adolescents with Sickle Cell Disease Constellation C Technology Access And Preferences For Smartphone Application Content Among Adults With Sickle Cell Disease And Their Caregivers Baltimore/ Annapolis A Training Approach for Newborn Screening Personnel in Nigeria Constellation D

4:15pm EDT

Sickle Cell Patients with Leg Ulcers have a Pro-Thrombotic Profile Constellation C Digital Engagement In The Sickle Cell Community Baltimore/ Annapolis The Importance of Social Work In Complex SCD Care: A Model For Clinical Intervention Constellation D

4:30pm EDT

Crizanlizumab Treatment is Not Asoociated with the Development of Proteinuria and Hematuria in Patients with Sickle Cell Disease: Sustain Study Safety Analysis Constellation C Novel Ways To Recruit New Health Care Professionals Into The Sickle Cell Arena Baltimore/ Annapolis The Forgotten Vital Sign: Use of A Distress Thermometer with Children, Adolescents and Young Adults Diagnosed with Sickle Cell Disease Constellation D

4:45pm EDT

Genome Editing to Fix the Sickle Cell Disease Causing Variant in Sickle Cell Patient Hematopoietic Stem Cells Constellation C Geography Seems To Be A Factor That Determines The Outcome Of Transition For Children With Sickle Cell Disease Into Adult Programs Baltimore/ Annapolis

5:00pm EDT

Correction of the Sickle Mutation in Hematopoietic Stem/Progenitor Cells with CRISPR/Cas9: The Berkeley/UCSF/UCLA Sickle Cell Clinical Translation Project Constellation C

5:15pm EDT

The Clinical-Stage SGC Stimulator Olinciguat Prevents Increase Of Plasma Biomarkers Of Intravascular Inflammation And Suppresses Leukocyte-Endothelial Interactions In Tnfa-Treated Mice Constellation C

6:00pm EDT

Red Carpet Reception and Photos Constellation Foyer

7:00pm EDT

UNITY SOIREE Constellation AB